SCHEMBL25829887

SCHEMBL25829887

COC(=O)CC(Cc1ccccc1)S(=O)(Cl)=N[Si](C)(C)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ PKM P14618 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ AGTR1 P30556 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MMP1 P03956 4/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25829889 0.86 MEN1 (0.43) ALDH1A1LMNAPKMHPGDTSHR
SCHEMBL25014618 0.78 MMP1 (0.41) ALDH1A1LMNAPKMHPGDTSHR
SCHEMBL21962906 0.77 MMP1 (0.49) RAB9AMMP1MMP2MMP3PDE4A
SCHEMBL21962930 0.73 MEN1 (0.53) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL22010636 0.71 F2 (0.39) POLBCA12CA9CA2
SCHEMBL22010524 0.70 KMT2A (0.46) MEN1KMT2APOLBCA12CA7
SCHEMBL22010522 0.67 POLB (0.39) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL25014625 0.67 ABCB1 (0.38) ALDH1A1LMNAPKMHPGDTSHR
SCHEMBL12268065 0.66 MMP8 (0.46) ALDH1A1LMNATSHRHSD17B10TP53
SCHEMBL9554305 0.66 ITGA4 (0.51) ALDH1A1LMNAPKMHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3880666-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2023-06-28 — — EP disclosed
Send feedback